Last updated: April 9, 2025
Sponsor: Insel Gruppe AG, University Hospital Bern
Overall Status: Active - Recruiting
Phase
N/A
Condition
Parkinson's Disease
Dyskinesias
Treatment
N/AClinical Study ID
NCT04366804
2020-00303
Ages 30-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Written informed consent;
PD, according to the MDS criteria;
Age of participants > 30 and < 75 years;
Being fluent in the language in which the scales are applied.
Exclusion
Exclusion Criteria:
- Presence of PD dementia (defined as MoCA score < 24).
Study Design
Total Participants: 300
Study Start date:
December 03, 2020
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Centre hospitalier régional universitaire de Besançon
Besançon, 25000
FranceCompleted
Universitätsklinikum Carl Gustav Carus
Dresden, 01307
GermanyCompleted
Aristotle University of Thessaloniki
Thessaloniki, 541 24
GreeceCompleted
Transilvania University
Brasov, 500036
RomaniaActive - Recruiting
Hospital Universitario Burgos
Burgos, 09006
SpainCompleted
Hospital Universitario Ramón y Cajal
Madrid, 28034
SpainSite Not Available
Ruber International Hospital
Madrid, 28034
SpainCompleted
Insel Gruppe AG University Hospital Bern
Bern, 3010
SwitzerlandCompleted
King's College London
London, WC2R 2LS
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.